TP53 mutations are enriched in the chromosomal instability (CIN) molecular subtype, which concentrates most HER2-amplified cases (71% of CIN cases were TP53 mutated, according to TCGA) [30]. The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.